|
MISSISSAUGA, ON--(Marketwired - January 07, 2016) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leading medical device company, announced it has completed a transaction that eliminates the 10% royalty obligation which was paid to the previous owner of its SIAscopy technology. To complete this transaction, MedX made a one-time payment of US$200,000 which was financed by a loan from a party related to its pharmacy channel partner. |
